MetLife Investment Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,140
| Closed | -$97.3K | – | 2851 |
|
|
2024
Q2 | $97.3K | Buy |
16,140
+1,579
| +11% | +$9.52K | ﹤0.01% | 2619 |
|
|
2024
Q1 | $162K | Hold |
14,561
| – | – | ﹤0.01% | 2308 |
|
|
2023
Q4 | $217K | Buy |
+14,561
| New | +$217K | ﹤0.01% | 2206 |
|
|
2023
Q3 | – | Sell |
-11,556
| Closed | -$86.8K | – | 2896 |
|
|
2023
Q2 | $86.8K | Buy |
+11,556
| New | +$86.8K | ﹤0.01% | 2761 |
|
|
2023
Q1 | – | Sell |
-11,755
| Closed | -$132K | – | 2790 |
|
|
2022
Q4 | $132K | Hold |
11,755
| – | – | ﹤0.01% | 2472 |
|
|
2022
Q3 | $112K | Buy |
+11,755
| New | +$112K | ﹤0.01% | 2628 |
|
|
2022
Q2 | – | Sell |
-10,745
| Closed | -$182K | – | 2858 |
|
|
2022
Q1 | $182K | Buy |
10,745
+3,965
| +58% | +$67K | ﹤0.01% | 2404 |
|
|
2021
Q4 | $146K | Hold |
6,780
| – | – | ﹤0.01% | 2256 |
|
|
2021
Q3 | $501K | Hold |
6,780
| – | – | ﹤0.01% | 1520 |
|
|
2021
Q2 | $371K | Hold |
6,780
| – | – | ﹤0.01% | 1750 |
|
|
2021
Q1 | $500K | Buy |
6,780
+2,409
| +55% | +$178K | ﹤0.01% | 1524 |
|
|
2020
Q4 | $377K | Hold |
4,371
| – | – | ﹤0.01% | 1619 |
|
|
2020
Q3 | $165K | Buy |
+4,371
| New | +$165K | ﹤0.01% | 1978 |
|